Peter WT Pisters, MD

The CEO Roundtable on Cancer has recognized the University of Texas MD Anderson Cancer Center with its 2022 Dr. Charles A. Sanders Award for collaborative scientific research in cancer.

“I am humbled and incredibly grateful to accept the Charles A. Sanders Life Sciences Award on behalf of the faculty and staff of MD Anderson,” said Peter WT Pisters, MD, president of MD Anderson Cancer Center. “This award exemplifies the outstanding dedication of our 23,000 MD Anderson team members and honors the patients and communities we serve. Each day, the spirit of teamwork and collaboration drives us as we collectively focus on unlocking the mysteries of cancer, whether through research, patient care, education, or prevention.”

The Sanders Award was established in 2013 to honor Charles A. Sanders, MD, former Chairman of Glaxo, and Chairman of the Foundation of the National Institutes of Health. The award recognizes “bold and venturesome” innovation and collaboration in clinical oncology research.

Dr. Sanders was the force behind many innovative life-lengthening and life-saving products. He also helped to shape health education and medical research in the United States from his days as chief executive of Massachusetts General Hospital, Harvard University.

The University of Texas MD Anderson Cancer Center is a founding member of the CEO Roundtable on Cancer and has been accredited as a Cancer Gold Standard employer since 2007. Dr. Pisters serves on the Board of the CEO Roundtable. He and key members of his team advise on research projects as well as health and well-being guidelines.

“MD Anderson and Peter Pisters represent the kind of leadership, innovation, collaboration, and patient-centric devotion that this award seeks to recognize and catalyze,” said Bill Louv, CEO of the CEO Roundtable on Cancer, who presented the award.

MD Anderson is recognized as one of the world’s most respected centers devoted exclusively to cancer patient care, research, education, and prevention.  As one of the largest cancer centers in the world, it has earned a reputation over more than eight decades of translating the most promising laboratory findings into innovative and effective treatments. MD Anderson has been named one of the top two hospitals in cancer care every year since U.S. News & World Report began its annual “America’s Best Hospitals” rankings in 1990.